Chu Besancon Hospital Jean Minjoz

Besançon 25030

0 studies enrolling now · 3 studies all time

What they study most

Endometrial Cancer, Metastatic Cholangiocarcinoma, Squamous Cell Carcinoma of the Anal Canal, Unresectable Cholangiocarcinoma

Studies at this site

• Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy. — Completed
• Carboplatin-paclitaxel With Retifanlimab or Placebo in Participants With Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (POD1UM-303/InterAACT 2). — Completed
• A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early